CORC  > 湖南大学
Clinical study on treating primary hepatic carcinoma with syndrome of stagnation of liver qi and spleen deficiency with combination of oral Ganxi Tablets and arsenic trioxide via transcatheter arterial chemoembolization
Wang Qimei; Wang Rongrong; Zhang Di; Pan Minqiu; Pan Bo; Deng Xiangsheng; Jiang Yilan
刊名China Journal of Traditional Chinese Medicine and Pharmacy
2016
卷号Vol.31 No.3页码:1121-1125
关键词Arsenic trioxide Ganxi Tablets Primary hepatic carcinoma Clinical research Stagnation of liver qi and spleen deficiency Transcatheter arterial chemoembolization
ISSN号1673-1727
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6072923
专题湖南大学
推荐引用方式
GB/T 7714
Wang Qimei,Wang Rongrong,Zhang Di,et al. Clinical study on treating primary hepatic carcinoma with syndrome of stagnation of liver qi and spleen deficiency with combination of oral Ganxi Tablets and arsenic trioxide via transcatheter arterial chemoembolization[J]. China Journal of Traditional Chinese Medicine and Pharmacy,2016,Vol.31 No.3:1121-1125.
APA Wang Qimei.,Wang Rongrong.,Zhang Di.,Pan Minqiu.,Pan Bo.,...&Jiang Yilan.(2016).Clinical study on treating primary hepatic carcinoma with syndrome of stagnation of liver qi and spleen deficiency with combination of oral Ganxi Tablets and arsenic trioxide via transcatheter arterial chemoembolization.China Journal of Traditional Chinese Medicine and Pharmacy,Vol.31 No.3,1121-1125.
MLA Wang Qimei,et al."Clinical study on treating primary hepatic carcinoma with syndrome of stagnation of liver qi and spleen deficiency with combination of oral Ganxi Tablets and arsenic trioxide via transcatheter arterial chemoembolization".China Journal of Traditional Chinese Medicine and Pharmacy Vol.31 No.3(2016):1121-1125.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace